BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
See today's BioWorld
Home
» Biopharma's near-term political destiny marred by uncertainty, need to reach the public
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Take it to the streets
Biopharma's near-term political destiny marred by uncertainty, need to reach the public
Jan. 14, 2020
By
Michael Fitzhugh
No Comments
SAN FRANCISCO – There's no time like now to think about the potential political changes, opportunities and challenges down the road for industry, Hogan Lovells partner Ivan Zapien told luncheon attendees during this year's Biotech Showcase.
BioWorld
Conferences